Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$322.67 - $449.65 $332,672 - $463,589
-1,031 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$353.85 - $487.79 $316,695 - $436,572
-895 Reduced 46.47%
1,031 $446,000
Q4 2021

Feb 11, 2022

BUY
$456.15 - $525.06 $293,304 - $337,613
643 Added 50.12%
1,926 $997,000
Q3 2021

Oct 12, 2021

BUY
$444.87 - $538.88 $24,912 - $30,177
56 Added 4.56%
1,283 $622,000
Q2 2021

Aug 09, 2021

BUY
$387.35 - $450.26 $93,738 - $108,962
242 Added 24.57%
1,227 $553,000
Q1 2021

May 10, 2021

BUY
$314.62 - $411.0 $309,900 - $404,835
985 New
985 $376,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.86B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.